Jubilant Will Acquire Contract Firm Draxis | Chemical & Engineering News
Volume 86 Issue 15 | p. 33 | Concentrates
Issue Date: April 14, 2008

Jubilant Will Acquire Contract Firm Draxis

Department: Business

India's Jubilant Organosys has agreed to acquire Draxis Health, a Canadian company that provides contract manufacturing of finished drugs and makes radiopharmaceuticals. The purchase price, about $255 million, represents a 41.2% premium over Draxis' stock price before it began to rise last month. Jubilant is already a large provider of custom research and manufacturing services. Chairman Shyam S. Bhartia says the purchase of Draxis will add to his company's contract manufacturing capabilities and take it into the radiopharmaceuticals business.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment